They were also slightly older than completers, more likely to be female, and about one year longer post-transplant–but these differences did not reach statistical significance ( Table 1 ).
← all excerpts
Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients.
1
—
—